Signature
/s/ Birgit Girshick
Issuer symbol
CRL
Transactions as of
30 Jan 2026
Net transactions value
-$647,952
Form type
4
Filing time
02 Feb 2026, 16:42:36 UTC
Previous filing
03 Jun 2025
Next filing
05 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Girshick Birgit Corporate Executive VP & COO C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ Birgit Girshick 02 Feb 2026 0001732091

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +9,500 +46% $0.000000 29,974 30 Jan 2026 Direct F1
transaction CRL Common Stock Tax liability $647,952 -3,061 -10% $211.68 26,913 30 Jan 2026 Direct
holding CRL Common Stock 45,470 30 Jan 2026 Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023.
F2 Reflects the exempt transfer pursuant to Rule 16a-13 of 45,470 shares held directly by the reporting person to a revocable trust controlled by the reporting person.